Sidebar Ads

Tuesday, May 1, 2018

Home » , » Pfizer revenue misses as breast cancer drug sales disappoint

Pfizer revenue misses as breast cancer drug sales disappoint

By  May 01, 2018  No comments
(Reuters) - Pfizer Inc's quarterly revenue missed analysts' estimates on Tuesday, hurt by lower-than-expected sales of blockbuster breast cancer drug Ibrance and arthritis drug Xeljanz.


from Reuters: Business News https://ift.tt/2jiXhBK

Related Posts:

0 comments:

Post a Comment

Trump is pressing the nuclear option on tariffs

The option of a 20% universal tariff is the only way to get to some of the massive revenues of trillions of dollars claimed by some of his a...